Literature DB >> 9634522

The 8765delAG mutation in BRCA2 is common among Jews of Yemenite extraction.

I Lerer, T Wang, T Peretz, M Sagi, L Kaduri, A Orr-Urtreger, J Stadler, H Gutman, D Abeliovich.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9634522      PMCID: PMC1377245          DOI: 10.1086/301924

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


× No keyword cloud information.
  12 in total

1.  Acceptance of preventive surgeries by Israeli women who had undergone BRCA testing.

Authors:  Vardit Kram; Tamar Peretz; Michal Sagi
Journal:  Fam Cancer       Date:  2006-05-25       Impact factor: 2.375

2.  Breast and ovarian cancer risk and risk reduction in Jewish BRCA1/2 mutation carriers.

Authors:  Brian S Finkelman; Wendy S Rubinstein; Sue Friedman; Tara M Friebel; Shera Dubitsky; Niecee Singer Schonberger; Rochelle Shoretz; Christian F Singer; Joanne L Blum; Nadine Tung; Olufunmilayo I Olopade; Jeffrey N Weitzel; Henry T Lynch; Carrie Snyder; Judy E Garber; Joellen Schildkraut; Mary B Daly; Claudine Isaacs; Gabrielle Pichert; Susan L Neuhausen; Fergus J Couch; Laura van't Veer; Rosalind Eeles; Elizabeth Bancroft; D Gareth Evans; Patricia A Ganz; Gail E Tomlinson; Steven A Narod; Ellen Matloff; Susan Domchek; Timothy R Rebbeck
Journal:  J Clin Oncol       Date:  2012-03-19       Impact factor: 44.544

3.  Recurrent TP53 missense mutation in cancer patients of Arab descent.

Authors:  Aviad Zick; Luna Kadouri; Sherri Cohen; Michael Frohlinger; Tamar Hamburger; Naama Zvi; Morasha Plaser; Eilat Avital; Shani Breuier; Firase Elian; Azzam Salah; Yael Goldberg; Tamar Peretz
Journal:  Fam Cancer       Date:  2017-04       Impact factor: 2.375

4.  Two BRCA1/2 founder mutations in Jews of Sephardic origin.

Authors:  Michal Sagi; Avital Eilat; Liat Ben Avi; Yael Goldberg; Dani Bercovich; Tamar Hamburger; Tamar Peretz; Israela Lerer
Journal:  Fam Cancer       Date:  2011-03       Impact factor: 2.375

Review 5.  The Jewish people: their ethnic history, genetic disorders and specific cancer susceptibility.

Authors:  Inbal Kedar-Barnes; Paul Rozen
Journal:  Fam Cancer       Date:  2004       Impact factor: 2.375

6.  The 1100delAT BRCA1 and the 8765delAG BRCA2 mutations: occurrence in high-risk non-Ashkenazi Jews and haplotype comparison of Jewish and non-Jewish carriers.

Authors:  Inbar Gal; Ruth Gershoni Baruch; Daniel Haber; Efrat Dagan; Shlomit Eisenberg-Barzilai; Jamal Zidan; Eitan Friedman
Journal:  Fam Cancer       Date:  2004       Impact factor: 2.375

7.  Identification of a founder BRCA2 mutation in Sardinia.

Authors:  M Pisano; A Cossu; I Persico; G Palmieri; A Angius; G Casu; G Palomba; M G Sarobba; P C Rocca; M F Dedola; N Olmeo; A Pasca; M Budroni; V Marras; A Pisano; A Farris; G Massarelli; M Pirastu; F Tanda
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

8.  Is there a difference in testosterone levels and its regulators in men carrying BRCA mutations?

Authors:  Hanan Goldberg; Liat Shavit Grievink; Roy Mano; Yaara Ber; Rachely Ozalbo; Sivan Tuval; Jack Baniel; David Margel
Journal:  Oncotarget       Date:  2017-10-10

9.  Origin and distribution of the BRCA2-8765delAG mutation in breast cancer.

Authors:  Grazia Palomba; Antonio Cossu; Eitan Friedman; Mario Budroni; Antonio Farris; Antonio Contu; Marina Pisano; Paola Baldinu; Maria C Sini; Francesco Tanda; Giuseppe Palmieri
Journal:  BMC Cancer       Date:  2007-07-19       Impact factor: 4.430

10.  First case report of an adrenocortical carcinoma caused by a BRCA2 mutation.

Authors:  Nada El Ghorayeb; Solange Grunenwald; Serge Nolet; Vanessa Primeau; Stéphanie Côté; Christine M Maugard; André Lacroix; Louis Gaboury; Isabelle Bourdeau
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.